TENX – tenax therapeutics, inc. (US:NASDAQ)

News

Tenax Therapeutics (TENX) was upgraded by Lifesci Capital to "strong-buy".
Tenax Therapeutics (TENX) had its "outperform" rating reaffirmed by William Blair.
Tenax Therapeutics GAAP EPS of -$0.38 beats by $0.03 [Seeking Alpha]
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com